unknown
Stage
1
Investors
About
Bloomsbury GTX is a clinical-stage biotechnology company focused on developing gene therapies for rare neurological and metabolic diseases, leveraging proven gene therapy technologies and collaborations with University College London and CDMOs.
Explore Bloomsbury GTX's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.